{
    "Trade/Device Name(s)": [
        "Xpert MRSA/SA Blood Culture",
        "GeneXpert Dx System",
        "GeneXpert Infinity-48s System",
        "GeneXpert Infinity-80 System"
    ],
    "Submitter Information": "Cepheid",
    "510(k) Number": "K190771",
    "Predicate Device Reference 510(k) Number(s)": [
        "K130894"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NQX",
        "OOI"
    ],
    "Summary Letter Date": "April 25, 2019",
    "Summary Letter Received Date": "March 26, 2019",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.1640"
    ],
    "Regulation Name(s)": [
        "Antimicrobial Susceptibility Test Powder"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "virology"
    ],
    "Analyte(s)": [
        "Methicillin-resistant Staphylococcus aureus (MRSA) DNA",
        "Staphylococcus aureus (SA) DNA"
    ],
    "Specimen Type(s)": [
        "Positive blood culture"
    ],
    "Specimen Container(s)": [
        "BD BACTEC Plus Aerobic/F bottle",
        "BacT/ALERT SA (Standard Aerobic) bottle",
        "VersaTREK REDOX 1 (aerobic) bottle"
    ],
    "Instrument(s)/Platform(s)": [
        "GeneXpert Dx System",
        "GeneXpert Infinity-48s System",
        "GeneXpert Infinity-80 System"
    ],
    "Method(s)/Technology(ies)": [
        "Automated real-time PCR",
        "Nucleic acid amplification"
    ],
    "Methodologies": [
        "DNA amplification",
        "Real-time PCR",
        "Hybridization probe detection"
    ],
    "Submission Type(s)": [
        "Test",
        "Assay",
        "Instrument",
        "Software",
        "Cartridge",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for Cepheid Xpert MRSA/SA Blood Culture test for qualitative detection of MRSA and SA DNA from positive blood culture bottles using GeneXpert real-time PCR platforms.",
    "Indications for Use Summary": "Qualitative in vitro diagnostic test for detecting Staphylococcus aureus (SA) and methicillin-resistant Staphylococcus aureus (MRSA) DNA directly from positive blood cultures, used with other laboratory tests and clinical data as an aid in detection; not intended for monitoring treatment.",
    "fda_folder": "Microbiology"
}